Search clinical trials for: FMS-like tyrosine kinase (FLT3) Inhibitor
Total 68265 results
-
PrECOG, LLC.Astellas Pharma IncActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Arog Pharmaceuticals, Inc.AvailableFLT3-ITD Mutation | FLT3/TKD Mutation | PDGFR-Alpha D842V | PDGFRA Gene AmplificationItaly
-
The University of Hong KongUnknownAML | FLT3-ITD MutationHong Kong
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; The Affiliated... and other collaboratorsRecruitingAcute Myeloid LeukemiaChina
-
Spirita Oncology, LLCTerminatedAML | MDS | CMMLUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...UnknownAML | FLT3-ITD Mutation | FLT3-TKD MutationItaly
-
Arog Pharmaceuticals, Inc.RecruitingNewly Diagnosed FLT3 Mutated AMLUnited States
-
The University of Hong KongCompletedAML | FLT3-ITD MutationHong Kong
-
University Hospital Inselspital, BerneTerminatedAML, AdultSwitzerland
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
Novartis PharmaceuticalsNo longer availableFLT3-mutated Acute Myeloid LeukemiaCanada
-
Robert ZeiserCompleted
-
Biomea Fusion Inc.RecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Mixed-Phenotype LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Myeloid Leukemia With FLT3/ITD MutationItaly
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedSecondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With Gene Mutations | FLT3 Tyrosine Kinase Domain Point MutationUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia...Completed
-
Zhejiang ACEA Pharmaceutical Co. Ltd.Recruiting
-
Princess Maxima Center for Pediatric OncologyDaiichi SankyoRecruitingAcute Myeloid Leukemia in ChildrenNetherlands
-
SCRI Development Innovations, LLCTerminatedLeukemia, Myeloid, AcuteUnited States
-
National Cancer Institute (NCI)CompletedKidney Cancer | Melanoma (Skin)United States
-
Göteborg UniversityCompleted
-
Taipei Medical University WanFang HospitalUnknownAcute Myeloid LeukemiaTaiwan
-
Duke UniversityNational Cancer Institute (NCI)CompletedColorectal Cancer | Metastatic CancerUnited States
-
Universitätsklinikum Hamburg-EppendorfCompletedAcute Myeloid LeukemiaGermany
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecruitingFLT3-positive Relapsed/Refractory Acute Myeloid LeukemiaChina
-
Nanfang Hospital of Southern Medical UniversityEnrolling by invitationAcute Myeloid Leukemia | FLT3-ITD Mutation | Brutons Tyrosine KinaseChina
-
Albert Einstein College of MedicineCelldex TherapeuticsTerminatedLung Cancer | Non Small Cell Lung CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedAcute Myeloid LeukemiaUnited States
-
Eli Lilly and CompanyCompletedAxial SpondyloarthritisUnited States, Puerto Rico, Russian Federation, Mexico, Poland, Argentina, Austria, Brazil, Canada, Czechia, Finland, Germany, Japan, Korea, Republic of, Netherlands, Romania
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Oryzon Genomics S.A.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Technische Universität DresdenPfizer; Novartis PharmaceuticalsRecruiting
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationCompletedRelapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior TherapiesUnited States
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
University of Rome Tor VergataActive, not recruiting
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsWithdrawnLeukemia | FLT3-Mutated Acute Myeloid Leukemia | FLT3-Mutated High-Risk Myelodysplastic Syndrome
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States
-
University of UlmNovartis PharmaceuticalsCompleted
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
The University of Hong KongCompletedAML | FLT3-ITD MutationHong Kong
-
Versailles HospitalActive, not recruiting
-
Albert Einstein College of MedicineCelldex TherapeuticsCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia | FLT3-mutated Acute Myeloid LeukemiaJapan, Korea, Republic of, Taiwan
-
Telios Pharma, Inc.Kartos Therapeutics, Inc.Active, not recruitingAcute Myeloid LeukemiaUnited States, Korea, Republic of, Spain, France, Austria, Australia, Germany, Italy
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
Astellas Pharma Korea, Inc.RecruitingAcute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationKorea, Republic of
-
National Cancer Institute (NCI)CompletedTherapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | FLT3 Gene Mutation | Acute Promyelocytic Leukemia With PML-RARA | Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1United States